Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 3

Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes

Total article views   HTML views PDF downloads Totals
11,463 Dovepress* 11,463+ 5,103 16,566
Totals 11,463 5,103 16,566
*Since 26 March 2010
+Since July 2016

View citations on Google Scholar